Courtney F Joseph
National Heart, Lung, and Blood Institute (NHLBI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Courtney F Joseph as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:57 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT06145282 · Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ FunctionNational Heart, Lung, and Blood Institute (NHLBI) · active not recruiting · Sickle Cell Disease · principal investigator
- N/ANCT05213572 · Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative TherapiesNational Heart, Lung, and Blood Institute (NHLBI) · recruiting · Mortality in Sickle Cell, Sickle Cell Cardiopulmonary Complications, Sickle Cell Organ Damage · principal investigator
- Ph1/Ph2NCT04008368 · Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease and Falling Donor Myeloid Chimerism LevelsNational Heart, Lung, and Blood Institute (NHLBI) · recruiting · Myeloid Chimerism · principal investigator
- N/ANCT03958643 · Best Noninvasive Predictor of Renal Function in Assessing Adult Sickle NephropathyNational Heart, Lung, and Blood Institute (NHLBI) · completed · Sickle Cell Disease · principal investigator
- Ph1/Ph2NCT03077542 · Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell DiseaseNational Heart, Lung, and Blood Institute (NHLBI) · active not recruiting · Sickle Cell Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Nonmyeloablative haploidentical peripheral blood stem cell transplantation in congenital anemiasZIAHL006211 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · fiscal years 2023 · $2,829,920 awarded in 2023Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.